NCT05436561View on ClinicalTrials.gov

Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies

PHASE2RecruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 1, 2022

Primary Completion Date

June 1, 2025

Study Completion Date

December 1, 2025

Conditions
Disease-free Survival
Interventions
DRUG

MBF-RIC

Reduced intensity conditioning regimen with fludarabine, busulfan and melphalan

Trial Locations (2)

200025

RECRUITING

Blood & Marrow Transplantation Center, RuiJin Hospital, Shanghai

Unknown

RECRUITING

Shanghai No 6 Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER